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INTRODUCTION 
Deep Brain Stimulation (DBS) is an accepted treatment for many psychiatric and neurologic disorders, including essential 
tremor.  The procedure has some distinct advantages over traditional surgical ablative procedures such as thalamotomy and 
pallidotomy in that it is adjustable, reversible, and no tissue is destroyed in the process.   The implanted device consists of 
three components: 1) intracranial electrodes, 2) a single or dual chamber programmable internal pulse generator (IPG) with 
battery, and 3) an extension cable that connects the two. The implantation procedure itself is staged with the first portion, 
"awake brain surgery," involving placement of the electrodes in the target area of the brain and subcutaneous tunneling of the 
extension cable from the electrodes to the site of the IPG. The second stage, usually a separate procedure from the first, 
involves implanting the IPG device into the infraclavicular area.1 
DISCUSSION 
 
Anesthesia for DBS is a challenge as a balance must be struck 
between analgesia and preventing interference with brain 
mapping and testing, all while preventing respiratory depression. 
The ideal agents should not interfere with microelectrode 
recording and testing and should have either no effect or an easily 
reversible effect on subcortical neuronal activity. While the surgery 
can be accomplished with either MAC or general anesthesia, MAC 
is preferred and offers a few advantages over general. MAC 
allows clinical symptoms like tremors to be evaluated during 
surgery as certain brain structures are stimulated by the 
electrodes. MAC also allows better control of patient 
hemodynamics which is important since hypertension leading to 
intracerebral hemorrhage is a potential complication of the 
procedure. Benzodiazepines and high-dose opioids interfere with 
microelectrode recording during stimulation testing, as subcortical 
areas are sensitive to GABA medications. Short-acting opioids, 
however, have little effect on microelectrode recording.2  
During our case, we employed a combination of 
dexmedetomidine, propofol and remifentanil as these drugs allow 
for appropriate sedation, analgesia and blood pressure control but 
are easily titratable to prevent respiratory depression. Propofol 
and remifentanil can be run early during placement of stereotactic 
head frame and stopped well before the macrostimulation phase 
of surgery, given that they are short-acting, while 
dexmedetomidine can be kept running as the patient is woken up 
since it has no effect on microelectrode recording.3  
CONCLUSION 
 
Anesthesia for DBS presents a challenge for anesthesiologists as patients 
must be appropriately sedated to comfortably undergo placement of 
intracranial electrodes but must also be easy to arouse for the 
macrostimulation phase of said electrodes so that they can be 
appropriately placed for treatment. Short-acting opioids like remifentanyl 
and the alpha-2 adrenergic agonist dexmedetomidine are good choices as 
neither will affect microelectrode recording. Propofol can also be used for 
portions of the procedure but should be appropriately timed to stop before 
the macrostimulation phase.  
CASE DESCRIPTION 
 
A 59-year-old right-handed woman with a 
history of type II diabetes mellitus, bronchitis 
and essential upper extremity tremors that 
started when she was a teenager. She stated 
that the tremors interfered with her ability to 
perform her activities of daily living, including 
drinking fluids without spilling, and writing. She 
denied head or voice tremor. She tried multiple 
medications with very minimal effect. She also 
tried a left thalamotomy but reported that she 
did not have any benefit of her right upper 
extremity. So she presented for DBS. Patient 
was anesthetized with dexmedetomidine bolus 
and continuous infusion (0.2-0.5mcg/kg/hr), 
propofol (30-80mcg/kg/min) and remifentanil 
(0.01-0.03mcg/kg/min) infusions which were 
titrated to effect before incision and weaned off 
prior to anticipated wake-up. While awake, 
patient was asked to complete tasks as 
microelectrodes stimulated the ventral 
intermediate thalamus of the nucleus 
bilaterally and tremor response was observed. 
Patient remained awake for about 1.5 hrs for 
correct positioning after which infusions were 
restarted, patient went back to sleep and 
electrodes were fixed into place. 
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